LogicBio Therapeutics (LOGC) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q2 EPS of ($0.23).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- TXO Energy Partners (TXO) PT Lowered to $19 at CapitalOne
- Trump on Iran: they're not going to make the kind of deal that I think is necessary
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
